drugset / Trial / NCT01525758
Study of SI000413 in Knee Osteoarthritis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate efficacy and safety of SI000413 in patients with knee osteoarthritis by orally administration and to determine optimal dose.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SI000413 | Unknown | 400 mg | Oral |
| Subject | SI000413 | Unknown | 600 mg | Oral |
| Subject | SI000413 | Unknown | 800 mg | Oral |